JPRN-UMIN000027728已完成未知
An examination of the effectiveness of a one-day of Acceptance and Commitment Therapy workshop and workbook for Irritable bowel syndrome symptoms in university students - The examination of the effectiveness of ACT of Irritable bowel syndrome non-patients
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 50years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Participants who presently undergoing psychopharmacological, or psychological treatment for gastrointestinal or psychiatric disorder 2.Person in whom organic disease is suggested by the presence of warning symptom (anemia, inflammatory reactions, or fecal occult blood, Unexplained weight loss in past 6 months, Persons with a family history of colon cancer) 3.Persons observed to have significant suicidal ideation 4.Any other person whom the principal investigator has determined to be unsuitable as a participant of the study
研究者
相似试验
进行中（未招募）
1 期
Investigation of safety and efficacy of once-daily semaglutide in obese subjects without diabetes mellitusObesityEUCTR2014-001540-38-GBovo Nordisk A/S957
进行中（未招募）
1 期
Investigation of safety and efficacy of once-daily semaglutide in obese subjects without diabetes mellitusMedDRA version: 18.1Level: PTClassification code 10029883Term: ObesitySystem Organ Class: 10027433 - Metabolism and nutrition disordersObesityEUCTR2014-001540-38-BEovo Nordisk A/S935
进行中（未招募）
1 期
Investigation of safety and efficacy of once-daily semaglutide in obese subjects without diabetes mellitusObesityEUCTR2014-001540-38-DEovo Nordisk A/S935
已完成
不适用
Comparative Study of Early Efficacy of Once-Daily Dosing between Silodosin 4mg and Tamsulosin 0.2mg for Voiding Symptoms Associated with Benign Prostatic HyperplasiaBenign Prostatic HyperplasiaJPRN-UMIN000011556Matsushita Urology Clinic60
尚未招募
1 期
comparsion between two drugs for the treatment of facial pigmentatioCTRI/2021/08/035625ROHAILKHAND MEDICAL COLLEGE